Navigation Links
Global Med Technologies(R), Inc. Submits ElDorado Donor(TM) to FDA
Date:10/18/2007

DENVER, Oct. 18 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, announced today that its Wyndgate Technologies(R) division ("Wyndgate") has submitted its ElDorado Donor(TM) software for a 510(k) clearance by the U.S. Food and Drug Administration (FDA). ElDorado Donor is currently not for sale in the U.S., pending 510(k) clearance by the FDA.

ElDorado Donor is intended as a comprehensive blood management software application designed to provide for the information system needs of a blood bank and donor centers. The software is designed to manage, automate, and control activities associated with donors, donor collections, testing, manufacturing, inventory, and distribution. ElDorado Donor was developed with scalability in mind and is designed to manage the system needs of diverse facilities, from small hospital blood banks to community blood centers, to regional and national centers, both domestically and internationally.

Utilizing an integrated modular configuration, ElDorado Donor is intended to offer functionality with flexibility to tailor features within the system to a facility's specific needs and to support process control from collection to distribution. The software is designed for ease-of-use and includes drop down lists and easy access find forms. Wyndgate's At-a-Glance(TM) bars are to provide a visual indication of the presence of relevant information that can be viewed and provide quick and easy access to the information. ElDorado Donor is designed to support the upcoming industry standard for labeling (ISBT128), as well as the ABC Codabar blood product labeling standard.

ElDorado Donor is to include safety checks for blood components, blood products, and other related supply items. These safety checks are to be performed throughout the system as part of the normal processing of donors, blood components, and other blood products. ElDorado Donor is to provide extensive manufacturing controls that can be tailored for a specific site depending on its processes.

The blood management software has been designed with guidance from Wyndgate's technology workgroup, comprised of leading industry representatives from around the world. Throughout the ElDorado Donor development process, the work group's contributions assisted the Company in delivering a feature-rich and user-friendly solution.

Miklos Csore, Vice President of Research and Development, commented, "Global Med Technologies and Wyndgate Technologies are delighted that ElDorado Donor has been submitted for FDA 510(k) clearance. Wyndgate's management and staff have strived to provide an innovative quality healthcare solution, which will assist our customers in meeting their business and regulatory needs. We wish to thank our technology work group, who has been invaluable throughout this process." Mr. Csore continued, "We look forward to the response from FDA regarding clearance for ElDorado Donor."

About Global Med Technologies, Inc.

Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the Donor Doc(TM) interactive donor health history questionnaire, SafeTrace(R) donor management system, and the SafeTrace Tx(R) advanced transfusion management system, recently patented, provide Vein-to-Vein(R) tracking from donor collection to patient transfusion.

For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com, http://www.peoplemed.com and http://www.wyndgate.com.

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.


'/>"/>
SOURCE Global Med Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Skin Cancer Research To Go Global
2. Dementia - a global problem
3. Obesity a global problem
4. Suggestions to reduce global heart disease burden
5. Drop in global deaths from measles
6. First global SARS meet opens
7. SARS-Free Taiwan to Mark End Phase of Global Fight
8. Prevent Global Warming by Becoming A Vegetarian
9. India To March Ahead in The Global HealthCare Competition
10. Global Outbreak Of Bird Flu Warning By Chinese Scientist
11. TWO India Doctors Listed in TIME for Contribution to Global Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... ... February 20, 2017 , ... For Immediate Release, Contact: ... leading provider of innovative software for connected home healthcare, today announced Orbita ... journey management for home healthcare. , Built on Orbita Health Cloud ...
(Date:2/20/2017)... , ... February 20, 2017 , ... The StayWell ... help health care providers better manage patient health risks, foster behavior change and improve ... library in the world, will present a demonstration of its video capability at StayWell ...
(Date:2/20/2017)... ... 2017 , ... Best Doctors® and IBM today announced that ... that want to help members of their workforce battling cancer. Through the Best ... suite of oncology offerings for insights on cancer treatment options, ranging from standard ...
(Date:2/20/2017)... ... 2017 , ... Johns Hopkins All Children's Hospital celebrated a major milestone with ... Friday marked the halfway point of construction and lifting of the final beam on ... as a center for innovation aimed at finding new discoveries and treatments for childhood ...
(Date:2/20/2017)... ... February 20, 2017 , ... Florida Hospital Pepin Heart ... ultrasound-enhanced thrombolysis machine, a state-of-the-art device that breaks up life-threatening blood clots by ... Family Foundation. , “We greatly appreciate this gift from Constellation Brands. We are ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... 21, 2017 Cognitive Computing for Cancer ... allowing a previously unattainable level of personalized treatment ... ability, it is anticipated that the Global Cancer ... by 2022. The growth of the market is ... platforms, rising installation of cognitive computing software in ...
(Date:2/21/2017)... 2017 Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the ... company will release its fourth quarter and full year ... February 28, 2017. The press release will be followed ... will be open to the public via telephone and ... its financial results and provide a business update. ...
(Date:2/21/2017)... Feb. 21, 2017  International Isotopes Inc. (OTCQB: INIS) ... placement with certain investors for approximately $3.4 million of ... Series C Convertible Redeemable Preferred Stock (the "Series C ... annual rate of 6% and is convertible into common ... use the proceeds for operating capital, to pay off ...
Breaking Medicine Technology: